Correlation Between Visa and SCI Pharmtech
Can any of the company-specific risk be diversified away by investing in both Visa and SCI Pharmtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and SCI Pharmtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and SCI Pharmtech, you can compare the effects of market volatilities on Visa and SCI Pharmtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of SCI Pharmtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and SCI Pharmtech.
Diversification Opportunities for Visa and SCI Pharmtech
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Visa and SCI is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and SCI Pharmtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCI Pharmtech and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with SCI Pharmtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCI Pharmtech has no effect on the direction of Visa i.e., Visa and SCI Pharmtech go up and down completely randomly.
Pair Corralation between Visa and SCI Pharmtech
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.87 times more return on investment than SCI Pharmtech. However, Visa Class A is 1.15 times less risky than SCI Pharmtech. It trades about 0.45 of its potential returns per unit of risk. SCI Pharmtech is currently generating about -0.29 per unit of risk. If you would invest 31,440 in Visa Class A on November 3, 2024 and sell it today you would earn a total of 2,740 from holding Visa Class A or generate 8.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 80.0% |
| Values | Daily Returns |
Visa Class A vs. SCI Pharmtech
Performance |
| Timeline |
| Visa Class A |
| SCI Pharmtech |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Visa and SCI Pharmtech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and SCI Pharmtech
The main advantage of trading using opposite Visa and SCI Pharmtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, SCI Pharmtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCI Pharmtech will offset losses from the drop in SCI Pharmtech's long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |